These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4589998)

  • 1. Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A.
    Tagg JR; Pihl EA; McGiven AR
    J Gen Microbiol; 1973 Nov; 79(1):167-9. PubMed ID: 4589998
    [No Abstract]   [Full Text] [Related]  

  • 2. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of bacteriocins in the disappearance in vivo of the L-phase of group A hemolytic streptococci.
    Clasener HA; Ensering HL
    Zentralbl Bakteriol Orig A; 1972 Oct; 222(1):34-9. PubMed ID: 4145150
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic products of Staphylococcus pyogenes. II. Possibilities of staphylococcus typing using bacteriocin].
    Vlajinac H; Krajinović S
    Srp Arh Celok Lek; 1978 Nov; 106(11):971-7. PubMed ID: 384557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the ultrastructure of hemolytic Streptococcus under the effect of penicillin and gramicidin C].
    Rimkunas A; Kats LN; Moroz AF
    Antibiotiki; 1970 Dec; 15(12):1099-102. PubMed ID: 4926438
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriocins from human and rodent streptococci.
    Kelstrup J; Gibbons RJ
    Arch Oral Biol; 1969 Mar; 14(3):251-8. PubMed ID: 4978137
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of mutacin b, an antibacterial substance produced by Streptococcus mutans strain BHT.
    Delisle AL
    Microbios; 1986; 46(186):21-8. PubMed ID: 3526096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-induced surface changes in microorganisms demonstrated by scanning electron microscopy.
    Greenwood D; O'Grady F
    Science; 1969 Mar; 163(3871):1076-8. PubMed ID: 4885070
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting of streptococci by zoocin A.
    Akesson M; Dufour M; Sloan GL; Simmonds RS
    FEMS Microbiol Lett; 2007 May; 270(1):155-61. PubMed ID: 17319876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptocin production and antistreptolysin O titre in rheumatic fever and rheumatic heart disease.
    Aggarwal P
    J Commun Dis; 1984 Dec; 16(4):307-10. PubMed ID: 6399061
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of dysgalacticin: a large heat-labile bacteriocin.
    Swe PM; Cook GM; Tagg JR; Jack RW
    J Antimicrob Chemother; 2009 Apr; 63(4):679-86. PubMed ID: 19213799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
    Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electronenmicroscopic Studies on Cells of Listeria monocytogenes Treated with Enterocin (author's transl)].
    Krämer J; Lenz W; Viebahn A; Brandis H
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):318-23. PubMed ID: 403713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The properties of cell wall hydrolysates of Streptococcus group A].
    Shmakovoa ZF; Kuznetsov VD; Serna FR; Degtereva OP
    Mikrobiol Zh (1978); 1992; 54(5):35-41. PubMed ID: 1453990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting production of the group A streptococcus bacteriocin SA-FF22.
    Jack RW; Tagg JR
    J Med Microbiol; 1992 Feb; 36(2):132-8. PubMed ID: 1740784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoelectronmicroscopic localization of cell wall antigens in streptococci. I. Comparative demonstration of M protein of Streptococcus pyogenes with ferritin-, peroxidase- and ferrocen-labelled antibodies].
    Wagner B; Wagner M
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):468-83. PubMed ID: 4145164
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of fimbriae in adherence of Streptococcus pyogenes to pharyngeal epithelial cells.
    Kasashima T; Suzuki K; Miyamoto N; Baba S; Tochikubo K
    Acta Otolaryngol Suppl; 1996; 525():40-3. PubMed ID: 8908268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of the variability of group A type M29 streptococcus on exposure to biologically active substances].
    Bitko SA; Dynga LO; Briko NI
    Lab Delo; 1991; (9):62-6. PubMed ID: 1721963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.